Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 06, 2022

COVID-19 Vaccine Effectively Protects Inflammatory Bowel Disease Patients Without Exacerbating the Disease

Clinical Gastroenterology and Hepatology


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Gastroenterology and Hepatology
COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation
Clin. Gastroenterol. Hepatol. 2021 Dec 23;[EPub Ahead of Print], R Lev-Tzion, G Focht, R Lujan, A Mendelovici, C Friss, S Greenfeld, R Kariv, A Ben-Tov, E Matz, D Nevo, Y Barak-Corren, I Dotan, D Turner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading